EMA increases general, non-pharmacovigilance fees by 0.3 per cent and 5.3 per cent from 1st April, 2022 Read more
US FDA grants priority review to Roche’s Actemra/RoActemra to treat COVID-19 in hospitalised adults Read more
Punjab government, Roche Pharma and Niramai Health Analytix launch ‘Pink Project’ initiative Read more
Biocon Biologics’ partner receives positive EU CHMP opinion for biosimilar human insulin for IV infusion Read more